Abstract:Research on new antitumor drugs is of great significance since most of the currently available drugs had the disadvantages of high toxicity,low effection and multidrug resistance against subset of solid tumors.Structure modification of natural products may still deliver new hope for antitumor drug discovery.Curcumin and flavonoids are two kinds of important natural products with antitumor activity for recent years.Based on SAR of curcuminoids and our previous work,15 new novel curcumin analogues were designed and synthesized according to pharmacophore and scaffold hopping principle.Structurally,the new analogues are 1,5-diarylpentadienones which possess one nitrogen-containing substitution at the position 5 on one of the aromatic ring.The target compounds 6a-6n and 6o were obtained using 4-hydroxy-3-methoxybenzaldehyde and 2,4-dihydroxybenzaldehyde as starting materials,respectively.After a series of reactions,and the new compounds were finally obtained via Mannich reaction.The structure of new compounds were confirmed by MS(ESI) and 1H-NMR.All of the new compounds were screened for antiproliferation activity against two human tumor cell lines in vitro.Most of the new analogues showed more potent antiproliferation activitities against both tested cells,than that of curcumin,with IC50 values below 10 μmol · L-1.The substituted groups introduced in the aromatic ring didn't make significant effect on their activity.The IC50 value of compound 6c and 6b was lower than that of curcumin and chalcone.The results indicated that compounds with alkaline groups,especially morpholine group,resulted in stronger potent activities.Compounds with cyclohexone(6m,6n) showed decreased activities than that with straight carbon chain(6a).Also,compounds with the second alkaline side chain(6h,6k) did not enhance the activities.The compound(6l) introduced a methy group at 4-position obviously resulted in the decreased antitumor activity.In summary,new compounds with five-carbon chain exhibited more potent activities than those with seven-carbon or three-carbon chain.However,substituted groups were introduced at the 4-positon and 2-position resulted in the decreased bioactivities of compounds.And compounds with a chlorine at the 2-position or trifluoromethyl at the 4-position of ring B enhanced antitumor activities.And the'drug-like' properties predicted by Discovery Studio 2.0 suggested that most of them may be well absorbed by intestine and have good bioavailability.

Synthesis of curcumin derivatives for suppression of castration-resistant prostate cancer

Synthesis of curcumin derivatives targeting androgen receptor for castration‐resistant prostate cancer therapy

1-Benzyloxy-5-phenyltetrazole derivatives highly active against androgen receptor-dependent prostate cancer cells

Synthesis and Antitumor Activity Study of Nitrogen-Containing Curcumin Derivatives

A monocarbonyl analogue of curcumin, 1,5-bis(3-hydroxyphenyl)-1,4-pentadiene-3-one (Ca 37), exhibits potent growth suppressive activity and enhances the inhibitory effect of curcumin on human prostate cancer cells

Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer.

Exploration on natural product anibamine side chain modification toward development of novel CCR5 antagonists and potential anti-prostate cancer agents

Discovery and Optimization of 1-(1 H -Indol-1-yl)ethanone Derivatives As CBP/EP300 Bromodomain Inhibitors for the Treatment of Castration-Resistant Prostate Cancer

Design and Synthesis of Dimethylaminomethyl-Substituted Curcumin Derivatives: Potent Anti-Inflammatory, Anti-Oxidant, and Radioprotection Activity, Improved Aqueous Solubility Compared with Curcumin

3-O-Carbamoyl-5,7,20-O-trimethylsilybins: Synthesis and Preliminary Antiproliferative Evaluation

Synthesis and biological evaluation of novel curcuminoid derivatives.

Synthesis, Anticancer Activity, and Preliminary Pharmacokinetic Evaluation of 4,4-Disubstituted Curcuminoid 2,2-bis(Hydroxymethyl)Propionate Derivatives

Synthesis and Biological Evaluation of Curcumin Derivatives Modified with Α-Amino Boronic Acid As Proteasome Inhibitors.

Design, synthesis and biological evaluation of novel thiosemicarbazone-indole derivatives targeting prostate cancer cells

1,3-Disubstituted-1,2,4-triazin-6-ones with potent activity against androgen receptor-dependent prostate cancer cells

The discovery of novel sanjuanolide derivatives as chemotherapeutic agents targeting castration-resistant prostate cancer

Evaluation of Biophysical As Well As Biochemical Potential of Curcumin and Resveratrol During Prostate Cancer

Discovery of novel 1,2,3,4-tetrahydrobenzo[4, 5]thieno[2, 3-c]pyridine derivatives as potent and selective CYP17 inhibitors.

Design, synthesis and biological evaluation of novel thiohydantoin derivatives as potent androgen receptor antagonists for the treatment of prostate cancer

Synthesis of new derivatives of 21-imidazolyl-16-dehydropregnenolone as inhibitors of 5α-reductase 2 and with cytotoxic activity in cancer cells

Synthesis and Biological Evaluation of Curcuminoid Derivatives.